Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neurosteroids as novel antidepressants and anxiolytics: GABA-A receptors and beyond
Charles F. Zorumski, Steven M. Paul, Douglas F. Covey, et al.
Neurobiology of Stress (2019) Vol. 11, pp. 100196-100196
Open Access | Times Cited: 282

Showing 1-25 of 282 citing articles:

Recent advances in understanding/management of premenstrual dysphoric disorder/premenstrual syndrome
Lara Tiranini, Rossella E. Nappi
Faculty Reviews (2022) Vol. 11
Open Access | Times Cited: 72
Understanding the mechanism of action and clinical effects of neuroactive steroids and GABAergic compounds in major depressive disorder
Andrew J. Cutler, Gregory W. Mattingly, Vladimir Maletic
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 60
GABAA receptors as targets for treating affective and cognitive symptoms of depression
Bernhard Lüscher, Jamie Maguire, Uwe Rudolph, et al.
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 9, pp. 586-600
Open Access | Times Cited: 50
The Role of HPA Axis and Allopregnanolone on the Neurobiology of Major Depressive Disorders and PTSD
Felipe Borges Almeida, Graziano Pinna, Helena Maria Tannhauser Barros
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5495-5495
Open Access | Times Cited: 78
GABAkines – Advances in the discovery, development, and commercialization of positive allosteric modulators of GABAA receptors
Rok Cerne, Arnold S. Lippa, Michael M. Poe, et al.
Pharmacology & Therapeutics (2021) Vol. 234, pp. 108035-108035
Open Access | Times Cited: 71
Steroid Hormone Sensitivity in Reproductive Mood Disorders: On the Role of the GABAA Receptor Complex and Stress During Hormonal Transitions
Sophie Schweizer-Schubert, Jennifer L. Gordon, Tory A. Eisenlohr‐Moul, et al.
Frontiers in Medicine (2021) Vol. 7
Open Access | Times Cited: 70
A systematic review of treatment for patients with burning mouth syndrome
Huann Lan Tan, Jared G. Smith, Jan Hoffmann, et al.
Cephalalgia (2021) Vol. 42, Iss. 2, pp. 128-161
Open Access | Times Cited: 65
Allopregnanolone: An overview on its synthesis and effects
Silvia Diviccaro, Lucia Cioffi, Eva Falvo, et al.
Journal of Neuroendocrinology (2021) Vol. 34, Iss. 2
Open Access | Times Cited: 63
The imidazodiazepine, KRM-II-81: An example of a newly emerging generation of GABAkines for neurological and psychiatric disorders
Jeffrey M. Witkin, Arnold S. Lippa, Jodi L. Smith, et al.
Pharmacology Biochemistry and Behavior (2022) Vol. 213, pp. 173321-173321
Closed Access | Times Cited: 39
Alleviating anxiety and taming trauma: Novel pharmacotherapeutics for anxiety disorders and posttraumatic stress disorder
Nicolas Singewald, Simone B. Sartori, Andreas Reif, et al.
Neuropharmacology (2023) Vol. 226, pp. 109418-109418
Open Access | Times Cited: 37
Neurosteroids: mechanistic considerations and clinical prospects
Jamie Maguire, Steven Mennerick
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 73-82
Open Access | Times Cited: 26
Impaired Endogenous Neurosteroid Signaling Contributes to Behavioral Deficits Associated With Chronic Stress
Najah Walton, Pantelis Antonoudiou, Lea Barros, et al.
Biological Psychiatry (2023) Vol. 94, Iss. 3, pp. 249-261
Open Access | Times Cited: 24
Multifaceted Actions of Neurosteroids
Ajeet Kumar, Mingxing Qian, Yuanjian Xu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access | Times Cited: 1
Cryo-EM: The Resolution Revolution and Drug Discovery
Taianá Maia de Oliveira, Lotte van Beek, Fiona Shilliday, et al.
SLAS DISCOVERY (2020) Vol. 26, Iss. 1, pp. 17-31
Open Access | Times Cited: 51
Site-specific effects of neurosteroids on GABAA receptor activation and desensitization
Yusuke Sugasawa, Wayland W.L. Cheng, John Bracamontes, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 50
Looking for Novelty in an “Old” Receptor: Recent Advances Toward Our Understanding of GABAARs and Their Implications in Receptor Pharmacology
David Castellano, Ryan D. Shepard, Wei Lü
Frontiers in Neuroscience (2021) Vol. 14
Open Access | Times Cited: 46
Neurosteroids and Neurotrophic Factors: What Is Their Promise as Biomarkers for Major Depression and PTSD?
Felipe Borges Almeida, Helena Maria Tannhauser Barros, Graziano Pinna
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1758-1758
Open Access | Times Cited: 43
Premenstrual Syndrome and Premenstrual Dysphoric Disorder as Centrally Based Disorders
Rossella E. Nappi, Laura Cucinella, David Bosoni, et al.
Endocrines (2022) Vol. 3, Iss. 1, pp. 127-138
Open Access | Times Cited: 29
Preclinical and clinical pharmacology of brexanolone (allopregnanolone) for postpartum depression: a landmark journey from concept to clinic in neurosteroid replacement therapy
Doodipala Samba Reddy, Robert H. Mbilinyi, Emily R. Estes
Psychopharmacology (2023) Vol. 240, Iss. 9, pp. 1841-1863
Open Access | Times Cited: 20
Neurosteroid enantiomers as potentially novel neurotherapeutics
Douglas F. Covey, Alex S. Evers, Yukitoshi Izumi, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 149, pp. 105191-105191
Open Access | Times Cited: 19
Neurosteroids as Novel Anticonvulsants for Refractory Status Epilepticus and Medical Countermeasures for Nerve Agents: A 15-Year Journey to Bring Ganaxolone from Bench to Clinic
Doodipala Samba Reddy
Journal of Pharmacology and Experimental Therapeutics (2023) Vol. 388, Iss. 2, pp. 273-300
Open Access | Times Cited: 16
GABAergic implications in anxiety and related disorders
Indu Arora, Pankaj Mal, Poonam Arora, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 724, pp. 150218-150218
Closed Access | Times Cited: 6
Androgen Therapy in Neurodegenerative Diseases
Vittorio Emanuele Bianchi, Laura Rizzi, Elena Bresciani, et al.
Journal of the Endocrine Society (2020) Vol. 4, Iss. 11
Open Access | Times Cited: 49
The role of allopregnanolone in depressive-like behaviors: Focus on neurotrophic proteins
Felipe Borges Almeida, Maurício Schüler Nin, Helena Maria Tannhauser Barros
Neurobiology of Stress (2020) Vol. 12, pp. 100218-100218
Open Access | Times Cited: 43
Transforming Discoveries About Cortical Microcircuits and Gamma Oscillations Into New Treatments for Cognitive Deficits in Schizophrenia
Vikaas S. Sohal
American Journal of Psychiatry (2022) Vol. 179, Iss. 4, pp. 267-276
Closed Access | Times Cited: 27
Page 1 - Next Page

Scroll to top